论文部分内容阅读
原发性肝癌(PHC)在无外科手术适应证的情况下,经导管肝动脉化疗栓塞术(TACE)仍是治疗的有效手段。但TA-CE治疗发生的严重并发症使部分患者死于围术期。通过多途径来加强围术期的管理,在肝癌TACE治疗中可以降低围术期病死率,有重要价值。现将我院324例行TACE治疗的情况报告如下?
Primary liver cancer (PHC) Transcatheter hepatic arterial chemoembolization (TACE) remains an effective treatment for patients without surgical indications. However, serious complications of TA-CE treatment led to some patients died of perioperative period. Through many ways to strengthen perioperative management, TACE in the treatment of liver cancer can reduce perioperative mortality, of great value. Now in our hospital 324 cases of TACE treatment report as follows?